Protagonist Therapeutics Inc Net Asset Quality Index
Protagonist Therapeutics Inc net asset quality index. Protagonist Therapeutics Inc (PTGX) has a Net Asset Quality Index of 92.0% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $701.69 Million minus total liabilities of $56.25 Million yields net assets of $645.44 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Protagonist Therapeutics Inc shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Protagonist Therapeutics Inc (2014–2024)
Net asset quality index of Protagonist Therapeutics Inc from 2014 to 2024. This chart shows how Protagonist Therapeutics Inc's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 92.0%, representing net assets of $645.44 Million against total assets of $701.69 Million USD. Check PTGX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Protagonist Therapeutics Inc Net Asset Quality Index by Year (2014–2024)
Protagonist Therapeutics Inc net asset quality index by year from 2014 to 2024. The table below presents the year-by-year Net Asset Quality Index for Protagonist Therapeutics Inc from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Protagonist Therapeutics Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 90.7% | $675.29 Million | $744.73 Million | $69.43 Million | ▼ -3.4 pp |
| 2023 | 94.1% | $336.68 Million | $357.95 Million | $21.27 Million | ▲ +7.1 pp |
| 2022 | 87.0% | $215.61 Million | $247.93 Million | $32.32 Million | ▲ +0.7 pp |
| 2021 | 86.3% | $300.02 Million | $347.69 Million | $47.67 Million | ▲ +0.1 pp |
| 2020 | 86.2% | $279.61 Million | $324.47 Million | $44.86 Million | ▲ +34.6 pp |
| 2019 | 51.6% | $79.96 Million | $154.92 Million | $74.95 Million | ▼ -29.1 pp |
| 2018 | 80.7% | $112.52 Million | $139.47 Million | $26.96 Million | ▲ +7.0 pp |
| 2017 | 73.7% | $120.63 Million | $163.73 Million | $43.10 Million | ▼ -19.5 pp |
| 2016 | 93.2% | $87.56 Million | $93.99 Million | $6.43 Million | ▲ +28.5 pp |
| 2015 | 64.6% | $9.60 Million | $14.85 Million | $5.25 Million | ▼ -12.4 pp |
| 2014 | 77.0% | $7.96 Million | $10.33 Million | $2.37 Million | — |